Advanced search

Instruments

Name	Stock exchange	Average volume	Price	Type
FAKTOR-OPTIONSSCHEIN - GRIFOLS CL. A	Börse Stuttgart	-	5.61 EUR	Certificat
FAKTOR-OPTIONSSCHEIN - GRIFOLS CL. A	Börse Stuttgart	-	2.85 EUR	Certificat
FAKTOR-OPTIONSSCHEIN - GRIFOLS CL. A	Börse Stuttgart	-	0.081 EUR	Certificat
FAKTOR-OPTIONSSCHEIN - GRIFOLS CL. A	Börse Stuttgart	-	- EUR	Certificat
FAKTOR-OPTIONSSCHEIN - GRIFOLS CL. A	Börse Stuttgart	-	- EUR	Certificat
FAKTOR-OPTIONSSCHEIN - GRIFOLS CL. A	Börse Stuttgart	-	- EUR	Certificat
FAKTOR-OPTIONSSCHEIN - GRIFOLS CL. A	Börse Stuttgart	-	0.042 EUR	Certificat
FAKTOR-OPTIONSSCHEIN - GRIFOLS CL. A	Börse Stuttgart	-	- EUR	Certificat
FAKTOR-OPTIONSSCHEIN - GRIFOLS CL. A	Börse Stuttgart	-	- EUR	Certificat
FAKTOR-ZERTIFIKAT - GRIFOLS CL. A	Börse Stuttgart	-	- EUR	Certificat

See all

News (31)

Grifols Announces Executive Changes	Feb. 06	CI
Grifols announces changes in governance to separate management from ownership as part of planned strategy	Feb. 06	AQ
Grifols S A : First half 2022 earnings release - Press release	22-11-10	PU
Grifols S A : highlights an increase in plasma and underscores innovation and sustainability as key growth pillars in its AGM	22-06-10	PU
Grifols S A : June 10 2022Grifols highlights an increase in plasma and underscores innovation and sustainability as key growth pillars in its AGM	22-06-10	PU
Grifols completes the acquisition of Biotest: a strategic and transformational transaction to accelerate growth and innovation	22-04-25	PU
April 25 2022Grifols completes the acquisition of Biotest: a strategic and transformational transaction to accelerate growth and innovation	22-04-25	PU
Grifols S A : announces its investment in Biotest	21-09-17	PU
Grifols S A : September 17, 2021Grifols announces its investment in Biotest	21-09-16	PU
Grifols S A : reaffirms its commitment to sustainability and innovation in its AGM and celebrates its 15th anniversary of being listed	21-05-21	PU
Grifols S A : fosters world's first scientific journal specialized in blood plasma	21-03-08	PR
Grifols S A : creates a Sustainability Committee to strengthen its long-term sustainable growth model	20-12-17	AQ
Grifols S A : December 16, 2020Grifols creates a Sustainability Committee to strengthen its long-term sustainable growth model	20-12-16	PU
Grifols S A : closes the acquisition of Green Cross fractionation plant in Canada and 11 plasma centers in the U.S.	20-10-02	AQ
Grifols S A : closes the acquisition of Green Cross fractionation plant in Canada and 11 plasma centers in the U.S.	20-10-01	PR
Grifols S A : closes the acquisition of Green Cross fractionation plant in Canada and 11 plasma centers in the U.S.	20-10-01	AQ
Grifols S A : October 1, 2020Grifols closes the acquisition of Green Cross fractionation plant in Canada and 11 plasma centers in the U.S.	20-10-01	PU
Grifols : July 20, 2020Grifols to acquire Green Cross plasma fractionation facility in Montreal and a plasma collection organization in the U.S. for US$460 million	20-07-20	PU
Grifols S A : to acquire Green Cross plasma fractionation facility in Montreal and a plasma collection organization in the U.S. for US$460 million	20-07-20	AQ
Grifols : S.A. annual accounts, auditor's report and directors' report for the financial year 2019	20-02-27	PU
Grifols : demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol	18-10-27	PR
Spain: Investment Plan for Europe - the EIB and Grifols sign a new loan agreement to advance research on rare and chronic diseases	18-09-07	PU
Grifols, S.A. Announces New Loan Agreement with European Investment Bank	18-09-07	CI
Grifols : and the European Investment Bank sign an Euros 85 million long-term loan to support its R+D+i initiatives Download (320.8 Kb)	18-09-07	PU
Grifols : culminates a year of growth and approves the distribution of a record EUR 265 million in dividends	18-05-25	PU
Grifols : culminates a year of growth and approves the distribution of a record EUR 265 million in dividends Download (79.4 Kb)	18-05-25	PU
Grifols : inaugurates a new plant of the Diagnostic Division in Brazil to manufacture storage and collection bags for blood components	17-11-22	PU
Grifols : inaugurates a new plant of the Diagnostic Division in Brazil to manufacture storage and collection bags for blood components Download (60.9 Kb)	17-11-22	PU
Grifols, S.A. Approves Ordinary and Preferred Dividend for the Year Ended December 31, 2015, Payable on 7 June 2016; Approves Board Changes	16-05-27	CI
Grifols : makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company Download (22.3 Kb)	15-12-14	PU
Grifols : makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company	15-12-14	PU

Companies (195)

VISA, INC. 549 B $

Visa, Inc. specializes in issuing and marketing payment cards. The group's activity is organized essentially into two areas: - sales of means of payment: credit cards, debit cards, on-line payment cards, prepaid cards, etc. (Visa, Visa Electron, PLUS, In ...

DARDEN RESTAURANTS, INC. 17 625 M $

Darden Restaurants, Inc. specializes in owning and operating restaurants. As of 28/05/2023, the group had 1,914 owned restaurants (of which 1,839 in the United States and Canada) and 75 franchised restaurants, distributed by name between Olive Garden (90 ...

NAVER CORPORATION 20 296 M $

Naver Corp is a Korea-based company principally engaged in the provision of Internet services. The Company provides business platform services such as general search and shopping search and others. The Company operates platforms such as LINE and SNOW and ...

HANMI SEMICONDUCTOR CO., LTD. 10 395 M $

Hanmi Semicondu-ctor Co., Ltd. is a Korea-based company mainly engaged in the manufacture of semiconductor equipment. The Company operates in two business segments: equipment segment and imported automobile segment. Its equipment segment manufactures semi ...

GRUPO MÉXICO, S.A.B. DE C.V. 50 681 M $

Grupo Mexico, S.A.B. de C.V. is a holding company. The Company's principal activities are in the mining-metallurgic industry, the exploration, exploitation and benefit of metallic and non-metallic ores, multimodal freight railroad service, and infrastruct ...

VINFAST AUTO LTD. 10 988 M $

VinFast Auto Ltd. is an automotive manufacturer. The Company manufactures and exports a portfolio of electric SUVs, e-scooters and e-buses across Vietnam, and the United States. It offers a full-scale mobility platform focused primarily on designing and m ...

RECKITT BENCKISER GROUP PLC 39 714 M $

Reckitt Benckiser Group plc specializes in the production and marketing of household cleaning products. The group also produces and sells personal care products and OTC remedies. Net sales break down by product family as follows: - OTC and health product ...

GRIFOLS, S.A. 5 989 M $

Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - ...

GRIFOLS, S.A. 5 989 M $

TAIWAN CEMENT CORP. 7 937 M $

Taiwan Cement Corporation is a Taiwan-based company principally engaged in the manufacture and sales of cement and ready-mixed concrete. The products of the Company include Portland cement type I, Portland cement type II, Portland cement type III, Portlan ...

1234Next

Insiders

Alberto Grifols Roura

Grifols Roura Family

Víctor Grifols Roura

Víctor Grifols Roura holds the position of Non-Executive Chairman for Grifols SA and Chairman at Instituto Grifols SA and Chairman & Chief Executive Officer at Arrahona Optimus SL (both are subsidiaries of Grifols SA). He is also on the board of Scranton Enterprises BV, Grifols USA, Inc. and Criteria Caixa SA. He received an undergraduate degree from the University of Barcelona.

Raimon Grifols Roura

Raimon Grifols Roura is Joint Chief Executive Officer & Executive Director at Grifols SA, Secretary of Instituto Grifols SA (a subsidiary of Grifols SA), Secretary for Xantic Spain SA, Secretary & Director at Stratos Global Spain SL and Secretary & Director at BRAINco Biopharma SL. He is also on the board of 10 other companies. In his past career he was Partner at Tojosnura SL and Secretary & Director at Grifols Shared Services North America, Inc. He received a graduate degree from the University of Barcelona.

Sergi Roura

Sergi Roura currently works as the President of Grifols Therapeutics, Inc.

Jeronimo Roura

Jeronimo Roura is a Non-Independent Non-Executive Director at Sohar Power Co. since 2013.
He previously worked as an Associate at Mena Infrastructure Fund Management.
Mr. Roura completed his undergraduate degree at Escuela Superior de Administración y Dirección de Empresas and holds an MBA from Instituto de Estudios Superiores de la Empresa.

No results for this search

Stock Market
Advanced search
V�ctor Grifols Roura